Clostridium botulinum type A toxin for the treatment of upper face animation lines: An Iranian experience

Journal of Cosmetic Dermatology

Volumn 6, Issue 3, 2007, Pages 152-158

  Farahvash, M Reza ^a   Arad, Simin ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BOSTON MEDICAL CENTER   (United States)

^c Department of Dermatology ^*  (United States)

Author keywords

Botox; Botulinum type A toxin; Dysport; Facial lines

Indexed keywords

BOTULINUM TOXIN A; HEMAGGLUTININ; SODIUM CHLORIDE;

ADULT; AGED; CANADA; CONTROLLED STUDY; COSMETIC INDUSTRY; DILUTION; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG USE; ECCHYMOSIS; ESTHETICS; FEMALE; HUMAN; INJECTION SITE SWELLING; IRAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTION; MUSCLE MASS; PRIORITY JOURNAL; PTOSIS; REVIEW; UNITED STATES; WRINKLE;

ADULT; AGED; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACE; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; IRAN; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 34548308502     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2007.00325.x     Document Type: Review

References (30)

1. Carruthers A, Carruthers J. Treatment of glabellar frown lines with botulinum A exotoxin. J Dermatol Surg Oncol 1992; 18: 17.
2. Borodic GE. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthal Reconstr Surg 1992; 8: 137.
3. Blitzer A, Brin MF, Keen MF, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993; 119: 1018-22.
4. Keen M,. Blitzer A, Aviv J et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994; 103: 656-63.
5. Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose response study. Dermatol Surg 1996; 22: 39-43.
6. Carruthers A, Kiene K, Carruthers J. Cosmetic use of botulinum A exotoxin. J Am Acad Dermatol 1996; 34: 788-97.
7. Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N; Botox Glabellar Lines II Study Group. Double blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003; 112: 1089.
8. Carruthers A, Carruthers J. Long-term safety review of subjects treated with botulinum toxin type A for cosmetic use. In: Proceedings of the 13th Congress of the European Academy of Dermatology and Venereology, Florence, Italy, November 17-21, 2004.
9. Carruthers A, Carruthers J. The treatment of glabellar furrows with botulinum A exotoxin. J Dermatol Surg Oncol 1990; 16: 83.
10. Fagien S. Extended use of botulinum toxin type A in facial aesthetic surgery. Aesthetic Surg J 1998; 18: 215-219.
11. Kaminer MS, Hruza GJ. Botulinum A exotoxin injections for photo aging and hyperhidrosis. In: Kaminer MS, Dover JS, Arndt KA, eds. Atlas of Cosmetic Surgery, 1st edn. Philadelphia: Saunders, 2002: 292-309.
12. Weider JM, Moy RL. Understanding botulinum toxin. Dermatol Surg 1998; 24: 1172-4.
13. Sommer B, Sattler G. Botulinum Toxin in Aesthetic Medicine. Berlin: Blackwell Science, 2001.
14. Warwick R, Williams P. Gray's Anatomy, 35th edn, London: Longman; 1973: 496-8.
15. Kane MA. Classification of crow's feet patterns among Caucasian women: the key to individualizing treatment. Plast Reconst Surg 2003; 112(Suppl.): 335.
16. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 2003; 5: 112.
17. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 2003; 112: 53S-54S.
18. Linder JS, Edmonson BC, Laquis SJ, Drewry RD Jr, Fleming JC. Skin cooling before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg 2002; 18: 441.
19. Edelstein C, Shorr N, Jacobs J, Balch K, Goldberg R. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998; 24: 1208-12.
20. Fields KA. Skin breakthroughs in the year 2000. Int J Fertil Womens Med 2000; 45: 175.
21. 2 laser resurfacing. Dermatol Surg 1999; 25: 259-361.
22. Dysport: Clostridium botulinum type A toxin-haemagglutinin complex [package insert]. Maidenhead, Berkshire, UK: Ipsen Limited; 2001.
23. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg 1998; 24: 1179-80.
24. Lowe NJ. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 1998; 24: 1216-18.
25. Carruthers A, Carruthers J. Botulinum toxin type A for the treatment of glabellar rhytides. Dermatol Clin 2004; 22: 137-44.
26. Guerrissi J, Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg 1997; 39: 447-53.
27. Goodman G. Outline toxin for the correction of hyperkinetic facial lines. Aust J Dermatol 1998; 39: 158.
28. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. In: AW Klein, ed. Tissue Augmentation in Clinical Practice: Procedure and Techniques. New York: Marcel Dekker; 1998: 207-36.
29. Carruthers JA, Lowe NJ, Menter MA et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46: 840-9.
30. Ellis DAF, Tan AKW. Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol 1997; 26: 92.